Cargando…

A comprehensive study on regulatory requirements for development and filing of generic drugs globally

The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be es...

Descripción completa

Detalles Bibliográficos
Autores principales: Handoo, Shweta, Arora, Vandana, Khera, Deepak, Nandi, Prafulla Kumar, Sahu, Susanta Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555014/
https://www.ncbi.nlm.nih.gov/pubmed/23373001
http://dx.doi.org/10.4103/2230-973X.104392
_version_ 1782256994989637632
author Handoo, Shweta
Arora, Vandana
Khera, Deepak
Nandi, Prafulla Kumar
Sahu, Susanta Kumar
author_facet Handoo, Shweta
Arora, Vandana
Khera, Deepak
Nandi, Prafulla Kumar
Sahu, Susanta Kumar
author_sort Handoo, Shweta
collection PubMed
description The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development.
format Online
Article
Text
id pubmed-3555014
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35550142013-01-31 A comprehensive study on regulatory requirements for development and filing of generic drugs globally Handoo, Shweta Arora, Vandana Khera, Deepak Nandi, Prafulla Kumar Sahu, Susanta Kumar Int J Pharm Investig Review Article The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3555014/ /pubmed/23373001 http://dx.doi.org/10.4103/2230-973X.104392 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Handoo, Shweta
Arora, Vandana
Khera, Deepak
Nandi, Prafulla Kumar
Sahu, Susanta Kumar
A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title_full A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title_fullStr A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title_full_unstemmed A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title_short A comprehensive study on regulatory requirements for development and filing of generic drugs globally
title_sort comprehensive study on regulatory requirements for development and filing of generic drugs globally
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555014/
https://www.ncbi.nlm.nih.gov/pubmed/23373001
http://dx.doi.org/10.4103/2230-973X.104392
work_keys_str_mv AT handooshweta acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT aroravandana acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT kheradeepak acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT nandiprafullakumar acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT sahususantakumar acomprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT handooshweta comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT aroravandana comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT kheradeepak comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT nandiprafullakumar comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally
AT sahususantakumar comprehensivestudyonregulatoryrequirementsfordevelopmentandfilingofgenericdrugsglobally